U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C4H8Cl3O4P
Molecular Weight 257.437
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of METRIFONATE

SMILES

COP(=O)(OC)C(O)C(Cl)(Cl)Cl

InChI

InChIKey=NFACJZMKEDPNKN-UHFFFAOYSA-N
InChI=1S/C4H8Cl3O4P/c1-10-12(9,11-2)3(8)4(5,6)7/h3,8H,1-2H3

HIDE SMILES / InChI

Molecular Formula C4H8Cl3O4P
Molecular Weight 257.437
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description
Curator's Comment: Description was created based on several sources including http://pmep.cce.cornell.edu/profiles/extoxnet/pyrethrins-ziram/trichlorfon-ext.html and http://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.1999.tb00083.x/pdf

Trichlorfon (Metrifonate), the organophosphorous cholinesterase inhibitor, O,O-dimethylhydroxy-2,2,2-trichlorethyl-phosphonate, has been used sporadically in the treatment of human schistosomiasis for a decade. It has selective and variable schistosomicidal activity against S. haematobium that results from its partial metabolism to a highly active anti-cholinesterase, dichlorvos. Schistosomal cholinesterase is more susceptible to this metabolite than that of the human host, but transient reductions in both plasma and erythrocyte cholinesterase activity are demonstrable at therapeutic dosage. However, despite early concerns about its potential toxicity, metrifonate is well tolerated and has been used effectively and extensively in large-scale control programmes. Its potential to enhance central nervous system cholinergic neurotransmission led to clinical trials for the treatment of people with Alzheimer's disease (AD).

CNS Activity

Curator's Comment: Blood-brain barrier permeability is shown in rat brain cortex and hippocampus

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
1.44 µM [IC50]
0.22 µM [IC50]
525.0 µM [Ki]
36.7 µM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets.
2011-03-28
Why so few drugs for Alzheimer's disease? Are methods failing drugs?
2010-11
Expression characteristics of potential biomarker genes in Tra catfish, Pangasianodon hypophthalmus, exposed to trichlorfon.
2010-09
Acetylcholinesterase biosensor based on Prussian blue-modified electrode for detecting organophosphorous pesticides.
2010-08-15
Impact of hookworm infection and deworming on anaemia in non-pregnant populations: a systematic review.
2010-07
Concurrent helminthic infection protects schoolchildren with Plasmodium vivax from anemia.
2010-06-21
Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats.
2010-06
Luminescent Mycena: new and noteworthy species.
2010-04-06
Immunohistological studies on neoplasms of female and male Onchocerca volvulus: filarial origin and absence of Wolbachia from tumor cells.
2010-04
Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA's ToxCast program.
2010-03-15
Mass spectrometric analyses of organophosphate insecticide oxon protein adducts.
2010-01
Tunga penetrans: painful lesions on the feet-the first imported case from Guinea-bissau.
2010
Enzyme Inhibition by Molluscicidal Components of Myristica fragrans Houtt. in the Nervous Tissue of Snail Lymnaea acuminata.
2010
Treatment of urinary schistosomiasis: methodological issues and research needs identified through a Cochrane systematic review.
2009-11
Ultrasonographic screening of urinary schistosomiasis infected patients in Agulu community, Anambra state, southeast Nigeria.
2009-10-28
Trichlorfon induces apoptosis in SH-SY5Y neuroblastoma cells via the endoplasmic reticulum?
2009-09-14
In vitro reactivation of trichlorfon-inhibited butyrylcholinesterase using HI-6, obidoxime, pralidoxime and K048.
2009-06
Do antenatal parasite infections devalue childhood vaccination?
2009-05-26
In vivo 1H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment.
2009-04-07
Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review.
2009-03-24
Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine.
2008-12
Improvement of acetylcholinesterase-based assay for organophosphates in way of identification by reactivators.
2008-10-19
Prize sessions.
2008-10
The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na, K)-, Mg-ATPase activities, antioxidant status, and learning performance of aged rats.
2008-08
Drugs for treating urinary schistosomiasis.
2008-07-16
Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial.
2008-07-12
The synergistic effect of concomitant schistosomiasis, hookworm, and trichuris infections on children's anemia burden.
2008-06-04
Controlling schistosomiasis: significant decrease of anaemia prevalence one year after a single dose of praziquantel in Nigerian schoolchildren.
2008-05-28
Incident diabetes and pesticide exposure among licensed pesticide applicators: Agricultural Health Study, 1993-2003.
2008-05-15
Pharmacodynamics of memantine: an update.
2008-03
Effect of glabridin from Glycyrrhiza glabra on learning and memory in mice.
2008-03
Lysophospholipase from the human blood fluke, Schistosoma japonicum.
2008-03
Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer's disease: a meta-analysis.
2008
A comparative study on the relationship between various toxicological endpoints in Caenorhabditis elegans exposed to organophosphorus insecticides.
2008
Noncholinesterase effects induced by organophosphate pesticides and their relationship to cognitive processes: implication for the action of acylpeptide hydrolase.
2007-12
Effects of trichlorfon on malondialdehyde and antioxidant system in human erythrocytes.
2007-12
[Different therapeutic efficacy of pralidoxime chloride PAM-Cl on AChE against acute toxicity of methamidophos, dichlorvos and omethoate].
2007-10
The effect of trichlorfon on acetylcholinesterase activity and histopathology of cultivated fish Oreochromis niloticus.
2007-09
Effects of trichlorfon on progesterone production in cultured human granulosa-lutein cells.
2007-08
Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics.
2007-06
The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat.
2007-06
Study on the mechanism of trichlorfon-induced inhibition of progesterone synthesis in mouse leydig tumor cells (MLTC-1).
2007-05-05
Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor.
2007-01
Calcium-independent tacrine-induced relaxation of rat gastric corpus smooth muscles.
2006-11
Response from Savioli and colleagues from the Department of Neglected Tropical Diseases, World Health Organization.
2006-06
Metrifonate for Alzheimer's disease.
2006-04-19
Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer's disease.
2006-03
Comparative brain cholinesterase-inhibiting activity of Glycyrrhiza glabra, Myristica fragrans, ascorbic acid, and metrifonate in mice.
2006
Inhibition-based determination of metrifonate in liquid and solid samples using the triple integration chemical hydrolysis-pervaporation-enzymic derivatisation.
2001-01-26
Pharmacokinetics of metrifonate and its rearrangement product dichlorvos in whole blood.
1991-02
Patents

Sample Use Guides

Treatment of urinary schistosomiasis: Adults and children: a dose of 7.5-10 mg/kg on three occasions at intervals of 2 weeks will cure 40-80% of cases. Even when viable worms remain, egg counts after one year are reduced to less than 20% of pre-treatment levels.
Route of Administration: Oral
In Vitro Use Guide
100 ug/ml trichlorfon added at the time of hormonally stimulated resumption of meiosis of follicle cell-enclosed mouse oocytes, 16 h before in vitro ovulation, induced significant rises in first meiotic nondisjunction in oocytes from preantral follicle culture.
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:21:09 GMT 2025
Edited
by admin
on Mon Mar 31 19:21:09 GMT 2025
Record UNII
DBF2DG4G2K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TRICHLORFON
GREEN BOOK   HSDB   ISO   MI   USAN   USP-RS  
USAN  
Preferred Name English
METRIFONATE
EP   INN   MART.   USP   WHO-DD   WHO-IP  
INN  
Official Name English
DETF
Common Name English
METRIFONATE [MART.]
Common Name English
Dimethyl (2,2,2-trichloro-1-hydroxyethyl)phosphonate
Systematic Name English
METRIFONATE [USP MONOGRAPH]
Common Name English
TRICHLORFON [IARC]
Common Name English
TRICHLORFON [USP-RS]
Common Name English
DIMETHYL (RS)-2,2,2-TRICHLORO-1-HYDROXYETHYLPHOSPHONATE
Systematic Name English
DIMETHYL (P)-(2,2,2-TRICHLORO-1-HYDROXYETHYL)PHOSPHONATE
Common Name English
METRIPHONATE
Common Name English
BAYER-L-1359
Code English
WEC-50
Code English
METRIFONATUM [WHO-IP LATIN]
Common Name English
TRICHLOROFON
Brand Name English
METRIFONATE [EP IMPURITY]
Common Name English
TRICLORFON
Common Name English
METRIFONATE [WHO-IP]
Common Name English
TRICHLORFON [HSDB]
Common Name English
BAY-A 9826
Code English
TRICHLORFON [USAN]
Common Name English
TRICHLORFON [ISO]
Common Name English
ENT-19,763
Code English
metrifonate [INN]
Common Name English
PHOSPHONIC ACID, (2,2,2-TRICHLORO-1-HYDROXYETHYL)-, DIMETHYL ESTER
Systematic Name English
Metrifonate [WHO-DD]
Common Name English
NSC-8923
Code English
TRICHLORFON [GREEN BOOK]
Common Name English
TRICHLORFON [MI]
Common Name English
METRIFONATE [USP IMPURITY]
Common Name English
BAYER L 1359
Code English
Classification Tree Code System Code
CFR 21 CFR 520.2520
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
CFR 21 CFR 520.1326B
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
CFR 21 CFR 520.2380E
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
CFR 21 CFR 520.2520D
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
CFR 21 CFR 520.1631
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
WHO-VATC QP53AF02
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
CFR 21 CFR 520.1326
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
CFR 21 CFR 520.2520A
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
EPA PESTICIDE CODE 57901
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
CFR 21 CFR 520.2520C
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
WHO-ATC P02BB01
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
WHO-VATC QP52AB01
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
CFR 21 CFR 520.1326A
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
IARC Trichlorfon
CFR 21 CFR 520.2520B
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
NCI_THESAURUS C47792
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
Code System Code Type Description
SMS_ID
100000080927
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
NCI_THESAURUS
C84225
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
EPA CompTox
DTXSID0021389
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
WIKIPEDIA
METRIFONATE
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
CAS
50924-44-2
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
SUPERSEDED
HSDB
881
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
EVMPD
SUB08919MIG
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
CAS
52-68-6
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
DRUG BANK
DB11473
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
CAS
56042-25-2
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
SUPERSEDED
NSC
8923
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
CAS
37333-09-8
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
SUPERSEDED
MESH
D014236
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
ALANWOOD
trichlorfon
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
CAS
66758-31-4
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
SUPERSEDED
MERCK INDEX
m11058
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY Merck Index
DRUG CENTRAL
1787
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
CHEBI
6908
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
ChEMBL
CHEMBL167150
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
RXCUI
1000581
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY RxNorm
FDA UNII
DBF2DG4G2K
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
RS_ITEM_NUM
1680801
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
INN
1704
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
ECHA (EC/EINECS)
200-149-3
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
CAS
1081812-64-7
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
SUPERSEDED
WHO INTERNATIONAL PHARMACOPEIA
TRICHLORFON
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY Description: A white or yellowish white, crystalline powder. Solubility: Sparingly soluble in water; very soluble in ethanol (~750 g/l) TS and acetone R. Category: Antischistosomal drug. Storage: Metrifonate should be kept in a tightly closed container, protected from light. Additional information: Even in the absence of light, Metrifonate is gradually degraded on exposure to a humid atmosphere, thedecomposition being faster at higher temperatures. CAUTION: Metrifonate must be handled with care, avoiding contact with the skin and inhalation of airborne particles. Definition: Metrifonate contains not less than 95.0% and not more than 101.0% of C4H8Cl3O4P, calculated with reference to the anhydrous substance.
PUBCHEM
5853
Created by admin on Mon Mar 31 19:21:09 GMT 2025 , Edited by admin on Mon Mar 31 19:21:09 GMT 2025
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
Related Record Type Details
ACTIVE MOIETY